← SynDRA
PAMAPIMOD
SynDRA canonical compound SYN0021676 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MAPK10 | MAPK11 | MAPK14 | MAPK8 | MAPK9 |
|---|
| Mechanism of action | p38 mapk inhibitor |
|---|
| Indication | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
- MAPK14
- MAPK10
- MAPK11
- MAPK8
- MAPK9
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- MAPK10 INHIBITOR
- MAPK11 INHIBITOR
- MAPK8 INHIBITOR
- MAPK9 INHIBITOR
Cross-references
Synonyms
- R-1503
- R1503
- Ro-4402257
- RO4402257
- UNII-8S2C9V11K4
- Pamapimod (R-1503, Ro4402257)
- CHEMBL1090089
- CHEBI:90685
- 8S2C9V11K4
- Ro4402257
- 6-(2,4-Difluorophenoxy)-2-{[3-Hydroxy-1-(2-Hydroxyethyl)propyl]amino}-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One
- Pamapimod [USAN:INN]
- 6-(2,4-Difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one
- 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one
- pamapimodum
- RefChem:928545
- MFCD25976551
- Pamapimod [USAN]
- Pamapimod (INN/USAN)
- PamapimodR-1503
- PamapimodR-1503?
- PAMAPIMOD [INN]
- PAMAPIMOD [WHO-DD]
- GTPL9915
- orb1300339
- SCHEMBL3636701
- SCHEMBL29379723
- SCHEMBL29429421
- C19H20F2N4O4
- GLXC-10768
- EX-A1084
- WZB81457
- BDBM50314070
- s8125
- AKOS032944999
- CCG-268715
- CS-5965
- compound 2b [PMID: 21375264]
Look up PAMAPIMOD in the interactive SynDRA portal →